Fortrea Holdings Inc. Common Stock
$19.93
-$0.35 (-1.73%)
$19.28Day Range$20.22
Key Statistics
Market Cap
$1.90B
Shares Outstanding
95.1M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jun 16, 2023
Round Lot
100
Locale
US
Trading Data
Day Open
$20.10
Day High
$20.22
Day Low
$19.28
Volume
3.11M
VWAP
$19.82
Prev Close
$20.28
Transactions
--
Acc. Volume
--
About Fortrea Holdings Inc. Common Stock
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
SERVICES-MEDICAL LABORATORIESSIC 807114,000 employees8 MOORE DRIVE, DURHAM, NC, 27709877-495-0816IPO Jun 16, 2023US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001965040
- Composite FIGI
- BBG01GZF9VY6
- Share Class FIGI
- BBG01GZF9W47
- Ticker Root
- FTRE
- SIC Code
- 8071
About Fortrea Holdings Inc. Common Stock (FTRE) Stock
Fortrea Holdings Inc. Common Stock (FTRE) closed the 2026-09-18 session at $19.93, down 1.73% versus the previous close (-0.35). The stock opened at $20.10 and traded between $19.28 and $20.22 during that session. Session trading volume was 3.1M shares. The volume-weighted average price (VWAP) is $19.82.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
Fortrea Holdings Inc. Common Stock has a market capitalization of $1.90 billion. The company operates in the SERVICES-MEDICAL LABORATORIES industry classification. FTRE is listed on the XNAS exchange. The company employs approximately 14,000 people. Fortrea Holdings Inc. Common Stock is headquartered in DURHAM, NC. The recorded listing date is 2023-06-16.
On this page you can find market FTRE stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SERVICES-MEDICAL LABORATORIES sector.